se of Individualized Homoeopathic medicines and Glycyrrhiza glabra mother tincture in the treatment of Hyperlipidemia
- Conditions
- Health Condition 1: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2022/07/043957
- Lead Sponsor
- ational Institute of Homoeopathy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
a) Patients of both sexes and all religions.
b)Patients with Body Mass Index (BMI):
For females 25â??30 and
For males 26â??30.
c) Patients already undergoing to regular therapy for hyperlipidemia, provided the medication are stopped completely at least 2 weeks prior study entry.
d) Patients giving written consent to participate in the study.
a) Patients of age group below 30 and above 70 years.
b) Patients with BMI:
Females, BMIâ?? <â??19,
Males, BMIâ?? <â??20
c) Patients who will be too sick for consultation.
d) Patients of diagnosed cases of systemic diseases, unstable mental or psychiatric illness or other uncontrolled or life threatening illness affecting quality of life or any organ failure, pregnancy and lactation, substance abuse and/or dependence, self reported immunocompromised state, and patients availing homeopathic treatment for chronic disease within last 6 months.
e) Patients unwilling to take part or not giving consent to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method